Genomics-informed drug-repurposing strategy identifies two therapeutic targets for preventing liver disease associated with metabolic dysfunction

Journal:

American Journal of Human Genetics

Published:

2025-08-07

DOI:

10.1016/j.ajhg.2025.06.014

Affiliations:

22

Authors:

22

Go to article

Institutions	Authors	Share
Vanderbilt University Medical Center (VUMC), United States of America (USA)	6.083333	0.28
University of Pennsylvania (Penn), United States of America (USA)	2.000000	0.09
VA Salt Lake City Health Care System, United States of America (USA)	2.000000	0.09
Corporal Michael J. Crescenz VA Medical Center (CMCVAMC), United States of America (USA)	2.000000	0.09
VA Palo Alto Healthcare System (VAPAHCS), United States of America (USA)	1.500000	0.07
Vanderbilt University (VU), United States of America (USA)	1.000000	0.05
NIH National Institute of Environmental Health Sciences (NIEHS), United States of America (USA)	1.000000	0.05
The University of Utah (Utah), United States of America (USA)	1.000000	0.05
Imperial College London (ICL), United Kingdom (UK)	1.000000	0.05
VA Tennessee Valley Healthcare System, United States of America (USA)	0.833333	0.04
Leipzig University, Germany	0.500000	0.02
Stanford University, United States of America (USA)	0.500000	0.02
Jesse Brown VA Medical Center (JBVAMC), United States of America (USA)	0.500000	0.02
University of Massachusetts Lowell (UMass Lowell), United States of America (USA)	0.500000	0.02
The University of Arizona (Arizona), United States of America (USA)	0.500000	0.02
Phoenix VA Health Care System (PVAHCS), United States of America (USA)	0.500000	0.02
Meharry Medical College, United States of America (USA)	0.333333	0.02
Atlanta VA Medical Center, United States of America (USA)	0.250000	0.01

Interested in Medical Biochemistry and Metabolomics?